• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Encephalitis after influenza and vaccination: a nationwide population-based registry study from Norway

tetano

Editor, Senior Moderator
Int J Epidemiol. 2017 Jul 27. doi: 10.1093/ije/dyx149. [Epub ahead of print]
[h=1]Encephalitis after influenza and vaccination: a nationwide population-based registry study from Norway.[/h] Ghaderi S[SUP]1[/SUP], St?rdal K[SUP]1,[/SUP][SUP]2[/SUP], Gunnes N[SUP]1[/SUP], Bakken IJ[SUP]1[/SUP], Magnus P[SUP]1[/SUP], H?berg SE[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Background:[/h] Influenza is known to be associated with various neurological complications, including encephalitis. We conducted a registry-based study to assess the risk of encephalitis after influenza and A(H1N1)pdm09 vaccine.
[h=4]Methods:[/h] Data from Norwegian national health registries during 2008-14 were linked using the unique personal identifiers given to all Norwegian residents ( N  = 5 210 519). Cox proportional-hazard models with time-varying variables were fitted to estimate hazard ratios (HRs) of encephalitis after influenza and A(H1N1)pdm09 vaccine, using the risk windows 0-7, 0-14, 0-30, 0-60, 0-90 and 0-180 days.
[h=4]Results:[/h] In Norway, 684 172 individuals received an influenza diagnosis and 2793 patients were hospitalized with encephalitis during 2008-14. The risk of encephalitis increased after influenza: HR, 7-day risk window: 47.8 (95% confidence interval (CI): 35.8-63.8), and the HR decreased for longer risk windows; HR, 180-day risk window: 3.8 (95% CI: 3.1-4.7). HR of encephalitis after influenza during the 2009 main pandemic wave using a 7-day risk window was 30.0 (95% CI: 10.8-83.2). We found no differences in the risk of encephalitis after the seasonal influenza compared with influenza during the 2009 main pandemic wave; HR, 7-day risk window: 1.3 (95% CI: 0.4-4.3). A(H1N1)pdm09 vaccine was not associated with the risk of encephalitis: HR, 14-day risk window: 0.6 (95% CI: 0.2-2.1).
[h=4]Conclusions:[/h] There was an increased risk of encephalitis following influenza but not after A(H1N1)pdm09 vaccine. The risk of encephalitis was highest in the first few weeks after influenza.


[h=4]KEYWORDS:[/h] A(H1N1)pdm09 vaccination; Encephalitis; Norway; influenza; meningitis; pandemic influenza

PMID: 29024996 DOI: 10.1093/ije/dyx149
 
Back
Top Bottom